Association Between Semaglutide Use and Risk of Back Pain in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Diabetes Research and Clinical Practice, vol
These references might help you discover more about the lawyer's services from people who have already hired them
Currently, the plan covers GLP-1 drugs for diabetes treatment but not for obesity
With the right support system, you wont have to navigate your journey alone
![semaglutide gastroparesis lawyer in michigan law office Ozempic Lawsuit [2026 Update] glp-1 nausea lawyer in michigan semaglutide gastroparesis lawyer in michigan](https://www.robertkinglawfirm.com/wp-content/uploads/2026/02/ozempic-lawsuit-settlement-factors-801x1024.webp)
[Ref] Renal Common (1% to 10%): Kidney failure (chronic hemodialysis patients) [Ref] Endocrine Common (1% to 10%): Parathyroid disorder [Ref] Respiratory Very common (10% or more): Pharyngitis (27%), cough increase (18%), dyspnea (11%), rhinitis (11%) Common (1% to 10%): Bronchitis, sinusitis [Ref] Dermatologic Common (1% to 10%): Pruritus, rash [Ref] Ocular Common (1% to 10%): Amblyopia, eye disorder [Ref] Genitourinary Common (1% to 10%): Urinary tract infection [Ref] Cardiovascular Very common (10% or more): Hypertension (21%), hypotension (19%) Common (1% to 10%): Atrial fibrillation, arrhythmia, cardiovascular disorder, electrocardiogram abnormal, palpitations, tachycardia, vascular disorder [Ref] Hypersensitivity Common (1% to 10%): Allergic reaction [Ref] Psychiatric Common (1% to 10%): Depression, anxiety, drug dependence, insomnia [Ref] Immunologic Very common (10% or more): Infection (24%) [Ref] References 1
![semaglutide gastroparesis lawyer in michigan law office Ozempic Lawsuit [2026 Update] glp-1 nausea lawyer in michigan semaglutide gastroparesis lawyer in michigan](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3891830498843310677)
Semaglutide (0.01 mg/kg) or vehicle was administered 3 h prior to water (IG)